2025-05-12 - Analysis Report
Okay, here's the report on Merck & Co. Inc. (MRK), incorporating the provided data and analysis requests.

## Merck & Co. Inc. (MRK) Stock Analysis

**Merck & Co., Inc. is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of a wide range of healthcare products.**

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (MRK):** 17.41%
*   **Cumulative Return (VOO):** 87.98%
*   **Return Difference:** -70.57%
*   **Relative Deviation:** 9.3 (This indicates that MRK's relative performance compared to VOO is currently at the 9.3rd percentile of its historical range. Meaning MRK is at the bottom of its historical relative performance compared to the S&P500)

**Analysis of Alpha, Beta, CAGR, and MDD Overlapping 3-Year Periods:**

| Year       | CAGR    | MDD    | Alpha   | Beta  | Cap(B) |
|------------|---------|--------|---------|-------|--------|
| 2015-2017  | 10.0%   | 58.6%  | -22.0%  | 0.1   | 106.0  |
| 2016-2018  | 49.0%   | 66.4%  | 27.0%   | 0.4   | 148.3  |
| 2017-2019  | 48.0%   | 66.4%  | 14.0%   | 0.9   | 181.4  |
| 2018-2020  | 26.0%   | 66.4%  | -4.0%   | 0.7   | 168.3  |
| 2019-2021  | 4.0%    | 65.6%  | -56.0%  | 0.5   | 171.3  |
| 2020-2022  | 20.0%   | 69.3%  | 11.0%   | 0.5   | 255.9  |
| 2021-2023  | 43.0%   | 69.3%  | 22.0%   | 0.3   | 258.5  |
| 2022-2024  | -3.0%   | 69.3%  | -24.0%  | 0.2   | 242.3  |
| 2023-2025  | -52.0%  | 70.2%  | -78.0%  | 0.2   | 190.8  |

**Analysis:**

*   **Underperformance:** MRK has significantly underperformed the S&P 500 over the period covered by the cumulative returns. The large negative difference (-70.57%) highlights this disparity.
*   **Alpha:**  Alpha fluctuates significantly, with several periods showing negative alpha, indicating underperformance relative to its benchmark (S&P 500) after accounting for risk. The most recent period (2023-2025) shows a particularly large negative alpha (-78.0%). This means that MRK has significantly underperformed expectations based on its beta and the market's performance.
*   **Beta:** Beta values are generally low (ranging from 0.1 to 0.9), suggesting that MRK's price is less volatile than the overall market.  The lower betas indicate MRK is less sensitive to market movements.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows considerable variation over the periods. Recent periods (2022-2025) show negative CAGR, indicating negative growth in the recent past.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, hovering around 60-70%, indicating significant potential for losses from peak to trough during these periods. The recent MDD of 70.2% for 2023-2025 implies that investors may have experienced substantial declines in their investment value.
*   **Capitalization:** The market capitalization (Cap(B)) data shows that MRK experienced growth in capitalization over the years, peaking around 2021-2023, but has since declined, particularly in the 2023-2025 period.

### 2. Recent Stock Price Movement

*   **Current Price:** 75.97
*   **Previous Close:** 77.65
*   **Change:** -2.16
*   **5-Day Moving Average:** 80.366
*   **20-Day Moving Average:** 80.254
*   **60-Day Moving Average:** 86.2015

**Analysis:**

*   **Recent Downtrend:** The current price is below both the previous close and the 5, 20, and 60-day moving averages. This indicates a short-term and medium-term downtrend.
*   **Moving Averages:** The fact that the 5-day moving average is below the 20-day moving average, and both are below the 60-day moving average, further confirms the downward trend. The stock price is moving downwards fairly rapidly.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3707 (Low Risk)
*   **RSI:** 48.88
*   **PPO:** 0.0594
*   **20-Day Relative Deviation Change:** -9.9 (Negative - indicating a short-term decrease)
*   **Expected Return (%):** -41.7%

**Analysis:**

*   **MRI:** The MRI suggests a low-risk investment environment for MRK.
*   **RSI:** An RSI of 48.88 is neutral, indicating that the stock is neither overbought nor oversold.
*   **PPO:** A PPO of 0.0594 suggests the stock price is slightly above its moving average, but not by a significant amount.
*   **Relative Deviation:** The negative change in relative deviation over 20 days confirms a short-term underperformance trend compared to the S&P 500.
*   **Expected Return:** The significantly negative expected return (-41.7%) is a major red flag.  This suggests that, based on current data and trends, the model predicts substantial underperformance compared to the S&P 500 over a longer investment horizon (2+ years) even with dollar cost averaging.
*   **Significant Price Change:** The `change` value of -2.16 from the `Last-market` data further underscores the recent negative price action and momentum for MRK.

### 4. Recent News & Significant Events

*   **May 12, 2025:** Major business developments, regulatory changes, or market events are affecting Merck & Co Inc (MRK).
*   **May 8, 2025:** Analysts are discussing Merck & Co Inc's (MRK) recent performance and its outlook in the context of industry trends and global economic factors.
*   **May 10, 2025:** Merck & Co Inc (MRK)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **May 11, 2025:** Market experts highlight both risks and opportunities for Merck & Co Inc (MRK), advising investors to monitor recent news and company announcements.

**Analysis:**

The news snippets indicate that MRK is currently experiencing a period of significant change and scrutiny. Analysts are actively discussing the company's performance, and the stock is exhibiting notable volatility. The general advice to monitor news and company announcements suggests that there is considerable uncertainty surrounding MRK's future prospects.

### 5. Overall Summary & Recommendations

**Summary:**

Merck & Co. (MRK) is currently underperforming the S&P 500 significantly. Recent price action confirms a downtrend, and technical indicators like the negative expected return raise concerns.  While the Market Risk Indicator shows 'Low Risk', other indicators suggest caution. The recent news highlights volatility and uncertainty surrounding the company.

**Recommendations:**

Given the current data, a cautious approach to MRK is warranted.

*   **Avoid or Reduce Exposure:** The negative expected return suggests that investors should consider reducing their exposure to MRK, especially if they have a long-term investment horizon.
*   **Monitor News Closely:** Investors should closely monitor news and company announcements to understand the underlying drivers of the recent volatility and performance issues.
*   **Further Research:** A deeper dive into the specific business developments, regulatory changes, and market events impacting MRK is essential before making any investment decisions.
*   **Consider Alternatives:** Given the negative expected return, investors should consider alternative investments that offer a more favorable risk-reward profile.
